These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
313 related articles for article (PubMed ID: 36418990)
1. Multidrug resistant bacterial infections in severely ill COVID-19 patients admitted in a national referral and teaching hospital, Kenya. Mutua JM; Njeru JM; Musyoki AM BMC Infect Dis; 2022 Nov; 22(1):877. PubMed ID: 36418990 [TBL] [Abstract][Full Text] [Related]
2. Extended-spectrum β-lactamase- producing gram-negative bacterial infections in severely ill COVID-19 patients admitted in a national referral hospital, Kenya. Mutua JM; Njeru JM; Musyoki AM Ann Clin Microbiol Antimicrob; 2023 Oct; 22(1):91. PubMed ID: 37838665 [TBL] [Abstract][Full Text] [Related]
3. ANTIBIOTIC SUSCEPTIBILITY OF ORGANISMS CAUSING URINARY TRACT INFECTION IN PATIENTS PRESENTING AT KENYATTA NATIONAL HOSPITAL, NAIROBI. Magale HI; Kassim IA; Odera SA; Omolo MJ; Jaoko WG; Jolly PE East Afr Med J; 2015 Jul; 92(7):333-337. PubMed ID: 27867208 [TBL] [Abstract][Full Text] [Related]
4. A Comparative Study on Bacterial Co-Infections and Prevalence of Multidrug Resistant Organisms among Patients in COVID and Non-COVID Intensive Care Units. Sathyakamala R; Peace AR; Shanmugam P J Prev Med Hyg; 2022 Mar; 63(1):E19-E26. PubMed ID: 35647371 [TBL] [Abstract][Full Text] [Related]
5. Bacterial infections and outcomes of inpatients with COVID-19 in the intensive care unit during the delta-dominant phase: the worst wave of pandemic in Iran. Akbari M; Dehghani Y; Shirzadi M; Pourajam S; Hosseinzadeh M; Sajadi M; Alenaseri M; Siavash M; Jafari L; Solgi H Front Public Health; 2024; 12():1411314. PubMed ID: 39314786 [TBL] [Abstract][Full Text] [Related]
6. Incidence and outcomes of multidrug-resistant gram-negative bacteria infections in intensive care unit from Nepal- a prospective cohort study. Siwakoti S; Subedi A; Sharma A; Baral R; Bhattarai NR; Khanal B Antimicrob Resist Infect Control; 2018; 7():114. PubMed ID: 30275945 [TBL] [Abstract][Full Text] [Related]
7. A multicenter analysis of the clinical microbiology and antimicrobial usage in hospitalized patients in the US with or without COVID-19. Puzniak L; Finelli L; Yu KC; Bauer KA; Moise P; De Anda C; Vankeepuram L; Sepassi A; Gupta V BMC Infect Dis; 2021 Feb; 21(1):227. PubMed ID: 33639862 [TBL] [Abstract][Full Text] [Related]
8. Increase of multidrug-resistant bacteria after the COVID-19 pandemic in a major teaching Hospital in Sicily (2018-2021). Amodio E; Pizzo S; Vella G; De Francisci V; Distefano SA; Giambelluca E; Graceffa D; Verso MG; Piro E; Giuffrè M; Giammanco GM; Calamusa G Int J Antimicrob Agents; 2024 May; 63(5):107123. PubMed ID: 38408493 [TBL] [Abstract][Full Text] [Related]
9. A Comparative Study of Bacterial Infections Between COVID-19 and Non-COVID-19 Patients With Respect to Different Isolates and Their Antibiotic Sensitivity Pattern. Arun N; Saurabh K; Muni S; Kumari N; Dev A Cureus; 2023 Jun; 15(6):e40387. PubMed ID: 37456417 [TBL] [Abstract][Full Text] [Related]
10. Secondary Bacterial Infection and Clinical Characteristics in Patients With COVID-19 Admitted to Two Intensive Care Units of an Academic Hospital in Iran During the First Wave of the Pandemic. Pourajam S; Kalantari E; Talebzadeh H; Mellali H; Sami R; Soltaninejad F; Amra B; Sajadi M; Alenaseri M; Kalantari F; Solgi H Front Cell Infect Microbiol; 2022; 12():784130. PubMed ID: 35281440 [TBL] [Abstract][Full Text] [Related]
11. Blood culture utilization and epidemiology of antimicrobial-resistant bloodstream infections before and during the COVID-19 pandemic in the Indonesian national referral hospital. Sinto R; Lie KC; Setiati S; Suwarto S; Nelwan EJ; Djumaryo DH; Karyanti MR; Prayitno A; Sumariyono S; Moore CE; Hamers RL; Day NPJ; Limmathurotsakul D Antimicrob Resist Infect Control; 2022 May; 11(1):73. PubMed ID: 35590391 [TBL] [Abstract][Full Text] [Related]
12. Bacterial Epidemiology and Antimicrobial Resistance Profiles in Children Reported by the ISPED Program in China, 2016 to 2020. Fu P; Xu H; Jing C; Deng J; Wang H; Hua C; Chen Y; Chen X; Zhang T; Zhang H; Chen Y; Yang J; Lin A; Wang S; Cao Q; Wang X; Deng H; Cao S; Hao J; Gao W; Huang Y; Yu H; Wang C Microbiol Spectr; 2021 Dec; 9(3):e0028321. PubMed ID: 34730410 [TBL] [Abstract][Full Text] [Related]
13. Multidrug-resistant Gram-negative bacterial infections and associated factors in a Kenyan intensive care unit: a cross-sectional study. Maina JW; Onyambu FG; Kibet PS; Musyoki AM Ann Clin Microbiol Antimicrob; 2023 Sep; 22(1):85. PubMed ID: 37710247 [TBL] [Abstract][Full Text] [Related]
14. Multidrug-Resistant and Virulent Organisms Trauma Infections: Trauma Infectious Disease Outcomes Study Initiative. Mende K; Akers KS; Tyner SD; Bennett JW; Simons MP; Blyth DM; Li P; Stewart L; Tribble DR Mil Med; 2022 May; 187(Suppl 2):42-51. PubMed ID: 35512375 [TBL] [Abstract][Full Text] [Related]
15. Bacterial and fungal coinfection among hospitalized patients with COVID-19: a retrospective cohort study in a UK secondary-care setting. Hughes S; Troise O; Donaldson H; Mughal N; Moore LSP Clin Microbiol Infect; 2020 Oct; 26(10):1395-1399. PubMed ID: 32603803 [TBL] [Abstract][Full Text] [Related]
16. Bacterial and fungal co-infections among ICU COVID-19 hospitalized patients in a Palestinian hospital: a retrospective cross-sectional study. Naseef HA; Mohammad U; Al-Shami N; Sahoury Y; Abukhalil AD; Dreidi M; Alsahouri I; Farraj M F1000Res; 2022; 11():30. PubMed ID: 35811795 [No Abstract] [Full Text] [Related]
17. Protective effect of SARS-CoV-2 preventive measures against ESKAPE and Escherichia coli infections. Gaspari R; Spinazzola G; Teofili L; Avolio AW; Fiori B; Maresca GM; Spanu T; Nicolotti N; De Pascale G; Antonelli M Eur J Clin Invest; 2021 Dec; 51(12):e13687. PubMed ID: 34599600 [TBL] [Abstract][Full Text] [Related]
18. A pandemic within a pandemic? Admission to COVID-19 wards in hospitals is associated with increased prevalence of antimicrobial resistance in two African settings. Elton L; Abdel Hamid MM; Tembo J; Elbadawi H; Maluzi K; Abdelraheem MH; Cullip T; Kabanda C; Roulston K; Honeyborne I; Thomason MJ; Elhag K; Mohammed A; Adam A; Mulonga K; Sikakena K; Matibula P; Kabaso M; Nakazwe R; Fwoloshi S; Zumla A; McHugh TD Ann Clin Microbiol Antimicrob; 2023 Apr; 22(1):25. PubMed ID: 37055793 [TBL] [Abstract][Full Text] [Related]
19. Multiple impacts of the COVID-19 pandemic and antimicrobial stewardship on antimicrobial resistance in nosocomial infections: an interrupted time series analysis. Li W; Yang X; Liu C; Liu X; Shi L; Zeng Y; Xia H; Li J; Zhao M; Yang S; Li X; Hu B; Yang L Front Public Health; 2024; 12():1419344. PubMed ID: 39086796 [TBL] [Abstract][Full Text] [Related]
20. Clinical characteristics and risk factors for bacterial co-infections in COVID-19 patients: A retrospective study. Gan Y; Zhang G; Sun H; Lyu X J Glob Antimicrob Resist; 2024 Sep; 38():6-11. PubMed ID: 38723711 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]